logo
Beyond Sleeping Pills: Er He Liao Offers a Holistic Remedy for Restful Nights

Beyond Sleeping Pills: Er He Liao Offers a Holistic Remedy for Restful Nights

Epoch Times24-04-2025

Sleepless nights can feel like a frustrating cycle that never ends. Tossing and turning while watching the hours slip away is a feeling millions experience at night. It's no surprise that the U.S. market for sleep aids has grown into a
However, if you are concerned about the side effects and potential dependency associated with pharmaceutical options, there is a holistic option worth considering. Enter Ear Harmony Crevice (Er He Liao, TE22), an acupoint recognized in traditional Chinese medicine (TCM) as a pathway to achieving inner calm and improving sleep quality.
Harmonizing Energies
Er He Liao, which translates to 'Ear Harmony Crevice,' is more than just a poetic name—it is classified as the exit point of the Triple Energizer meridian, one of the
While modern TCM practitioners debate the importance of exit and entry points, many agree that these locations are crucial for balancing excesses of
Additionally, Er He Liao has a soothing effect on the 'shen,' or spirit, making it especially beneficial for those experiencing restlessness, anxious thoughts, or sleep disturbances. Furthermore, if you experience head pain or pressure, the Er He Liao acupoint may relieve physical discomfort and mental tension.
A Built-In Diagnostic Tool
Another fascinating element of Er He Liao is its location just above the superficial temporal artery. If you rest your fingers gently just in front of your ear, near the hairline, you might feel its pulse beating beneath the skin. According to some TCM practitioners, the rhythm and quality of this pulse can offer clues about your sleep health. A gentle, even pulse on both sides suggests good circulation in the head region and thus good sleep quality, while an asymmetrical or pounding sensation might reflect internal disturbances affecting sleep.
Modern Science: A New Lens on an Old Point
Ancient theories often discuss concepts of energy and meridians, but today's researchers are investigating Er He Liao from a biomedical perspective, particularly regarding its role in pain management.
One clinical
Additionally, the treatment altered crucial chemical markers by reducing inflammatory and pain-related compounds, while increasing levels of 5-HT, a neurotransmitter that helps regulate mood and pain. Patients felt physically better and reported an improved quality of life.
How to Locate and Stimulate Er He Liao
Finding Er He Liao is straightforward. It is located where your ear connects to your head, specifically at the root of the auricle, along the edge of your temple's hairline. You should be able to feel a pulse at this spot. When you press on the acupoint, it may feel sore or tender to the touch.
How to Stimulate Er He Liao for Better Rest
Finger Pressure:
Apply gentle pressure for three to five seconds, release for three seconds, and repeat this rhythm for one to three minutes on each side.
Circular Massage:
Use your thumb or index finger to massage the area in slow, calming circles for one to three minutes.
Herbal Patch:
For deeper relaxation, try applying an herbal patch overnight.
Advanced Methods:
Techniques like acupuncture, moxibustion (a gentle heat therapy with dried mugwort), or gua sha (gentle scraping of the skin to boost circulation) should only be done by trained professionals.
Precautions:
Because of its proximity to the artery, Er He Liao point can be sensitive. Start gently, and increase pressure only if it's comfortable. Skip direct stimulation if you have injuries near the area, and consult a professional before trying advanced methods. If you're using herbal patches, read ingredient lists carefully to avoid aggressive chemicals, especially if your skin is prone to allergic reactions.
A Natural Wind-Down Ritual
Rest doesn't have to come in the form of a pill. Incorporating Er He Liao stimulation into your bedtime routine might give your body and mind the nudge they need toward peaceful slumber. It's a no-cost, low-effort, side-effect-free practice that could help anchor your evenings in calm. Try it for a few nights and see what changes. Chances are, better sleep is just a touch away.
Related Stories
4/22/2025
4/8/2025
TCM expert Shihhsiang Hung reviewed this article for accuracy and clarity.
Views expressed in this article are the opinions of the author and do not necessarily reflect the views of The Epoch Times. Epoch Health welcomes professional discussion and friendly debate. To submit an opinion piece, please follow these guidelines and submit through

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Aethera Biotech Forges Strategic Collaboration with China's Shang Renée Skincare to Introduce CROP (Controlled Release of Optimized Plants) Patent Technology into Chinese Market
Aethera Biotech Forges Strategic Collaboration with China's Shang Renée Skincare to Introduce CROP (Controlled Release of Optimized Plants) Patent Technology into Chinese Market

Yahoo

time3 hours ago

  • Yahoo

Aethera Biotech Forges Strategic Collaboration with China's Shang Renée Skincare to Introduce CROP (Controlled Release of Optimized Plants) Patent Technology into Chinese Market

ROME, June 06, 2025--(BUSINESS WIRE)--Aethera Biotech officially announced a strategic partnership with Chinese premium skincare brand Shang Renée, marking the latter as Aethera Biotech's first collaborative partner in the Chinese market. This collaboration not only introduces the internationally pioneering CROP patent technology to China but has also led to the joint establishment of the CELL Laboratory in Italy, laying a robust foundation for scientific innovation in skincare. CROP technology is an exclusive global patent held by Aethera Biotech. This innovation utilizes 100% natural laboratory cultivation to develop plant callus tissue cells (phytocomplexes), fully preserving the highly active components and regenerative properties of plants. The CELL Laboratory will focus on cellular research of core ingredients such as EchinAge CROP-G and other rare botanical specimens for Shang Renée, providing robust scientific support for the brand's skincare formulations. The EchinAge CROP-G compound, cultivated through this proprietary technology, exhibits elevated concentrations of modularized polyphenols and polysaccharides. Compared to conventional Echinacea extracts, EchinAge CROP-G demonstrates significantly enhanced polyphenolic content. Its dermatological efficacy manifests through three primary mechanisms: Rapid oxidative stress reduction via ROS suppression; Dual-targeted anti-inflammatory action through inhibition of iNOS and COX2 expression; Skin firming via attenuation of fibroblast-protective activity. Clinically validated outcomes include measurable improvements in skin texture refinement and reduction of contour wrinkles, supported by comprehensive experimental data. Centered on the philosophy of "Natural Regeneration," Shang Renée is committed to delivering transformative solutions for skin repair, firming, and wrinkle reduction. This partnership will leverage Aethera Biotech's expertise in plant cell cultivation, synergizing with active compounds like EchinAge CROP-G to develop groundbreaking skincare innovations. The CEO of Aethera Biotech stated: "We are thrilled to deepen our collaboration with Shang Renée. Through joint research at the CELL Laboratory, we aim to translate avant-garde plant cell technologies into tangible skincare advancements, offering Chinese consumers purer and more efficacious skincare experiences." View source version on Contacts Claire Chanservice@

Aethera Biotech Forges Strategic Collaboration with China's Shang Renée Skincare to Introduce CROP (Controlled Release of Optimized Plants) Patent Technology into Chinese Market
Aethera Biotech Forges Strategic Collaboration with China's Shang Renée Skincare to Introduce CROP (Controlled Release of Optimized Plants) Patent Technology into Chinese Market

Business Wire

time3 hours ago

  • Business Wire

Aethera Biotech Forges Strategic Collaboration with China's Shang Renée Skincare to Introduce CROP (Controlled Release of Optimized Plants) Patent Technology into Chinese Market

ROME--(BUSINESS WIRE)--Aethera Biotech officially announced a strategic partnership with Chinese premium skincare brand Shang Renée, marking the latter as Aethera Biotech's first collaborative partner in the Chinese market. This collaboration not only introduces the internationally pioneering CROP patent technology to China but has also led to the joint establishment of the CELL Laboratory in Italy, laying a robust foundation for scientific innovation in skincare. CROP technology is an exclusive global patent held by Aethera Biotech. This innovation utilizes 100% natural laboratory cultivation to develop plant callus tissue cells (phytocomplexes), fully preserving the highly active components and regenerative properties of plants. The CELL Laboratory will focus on cellular research of core ingredients such as EchinAge CROP-G and other rare botanical specimens for Shang Renée, providing robust scientific support for the brand's skincare formulations. The EchinAge CROP-G compound, cultivated through this proprietary technology, exhibits elevated concentrations of modularized polyphenols and polysaccharides. Compared to conventional Echinacea extracts, EchinAge CROP-G demonstrates significantly enhanced polyphenolic content. Its dermatological efficacy manifests through three primary mechanisms: Rapid oxidative stress reduction via ROS suppression; Dual-targeted anti-inflammatory action through inhibition of iNOS and COX2 expression; Skin firming via attenuation of fibroblast-protective activity. Clinically validated outcomes include measurable improvements in skin texture refinement and reduction of contour wrinkles, supported by comprehensive experimental data. Centered on the philosophy of "Natural Regeneration," Shang Renée is committed to delivering transformative solutions for skin repair, firming, and wrinkle reduction. This partnership will leverage Aethera Biotech's expertise in plant cell cultivation, synergizing with active compounds like EchinAge CROP-G to develop groundbreaking skincare innovations. The CEO of Aethera Biotech stated: "We are thrilled to deepen our collaboration with Shang Renée. Through joint research at the CELL Laboratory, we aim to translate avant-garde plant cell technologies into tangible skincare advancements, offering Chinese consumers purer and more efficacious skincare experiences."

ZEISS CLARUS 700 Receives NMPA Approval in China
ZEISS CLARUS 700 Receives NMPA Approval in China

Yahoo

time15 hours ago

  • Yahoo

ZEISS CLARUS 700 Receives NMPA Approval in China

ZEISS Medical Technology expands retinal insights for ophthalmologists with ultra-widefield, high-resolution imaging capabilities JENA, Germany and SHANGHAI, June 5, 2025 /CNW/ -- ZEISS Medical Technology announced today that the CLARUS® 700 from ZEISS has received National Medical Products Administration (NMPA) approval in China, offering advanced retinal diagnostic capabilities with ultra-widefield, high-resolution images in True Color and unsurpassed quality. The fundus imaging device with Fluorescein Angiography helps eye care specialists in China unlock the full potential of their clinic's retina workflow to support improved patient vision preservation. "ZEISS CLARUS 700 represents a major step forward in retinal imaging," emphasizes Anuj Kalra, Head of Chronic Disease Management at ZEISS Medical Technology. "By seamlessly integrating ultra-widefield Fluorescein Angiography (FA) imaging with true-color reproduction, this system delivers unprecedented clarity for comprehensive visualization from the macular region to the extreme retinal periphery, enhancing efficiency and supporting precise decision-making within the ZEISS Retina Workflow." "Integrating ultra-widefield imaging, unsurpassed clarity, and AI-enhanced capture, the CLARUS 700 redefines fundus angiography benchmarks. It will provide unparalleled diagnostic precision for Chinese doctors and unprecedented comfort for their patients," says Maxwell Liu, Head of Sales & Services at ZEISS Medical Technology China. Ultra-widefield fluorescein angiography serves as a highly valuable examination tool for assessing nonperfused retinal areas. The ZEISS CLARUS 700 HD ultra-widefield fundus imaging camera is an advanced retinal imaging system that provides True Color, high-resolution images. It captures 133°1 in a single image and up to 267° with multiple captures, offering detailed views of the retina. Equipped with both fluorescein angiography and live infrared imaging capabilities, the CLARUS 700 aids in diagnosing and monitoring retinal diseases2. Furthermore, the fundus imaging camera offers innovative technology features including PrecisionFocus for quickly seeing details in the regions of interest, QuickCompare to compare pathology changes observed in past patient visits, and AutoBright so ophthalmologists can spend more time analyzing images and less time adjusting them. More information about the CLARUS® 700 from ZEISS can be found here. 1 CLARUS 700#white-paper2 Xiao, Y., Dan, H., Du, X. et al. Assessment of early diabetic retinopathy severity using ultra-widefield Clarus versus conventional five-field and ultra-widefield Optos fundus imaging. Sci Rep 13, 17131 (2023). Not all products, services or offers are approved or offered in every market and approved labeling and instructions may vary from one country to another. For country-specific product information, see the appropriate country website. Product specifications are subject to change in design and scope of delivery as a result of ongoing technical development. The statements of the healthcare professionals reflect only their personal opinions and experiences and do not necessarily reflect the opinion of any institution that they are affiliated with. The healthcare professionals alone are responsible for the content of their experience reported and any potential resulting infringements. Carl Zeiss Meditec AG and its affiliates to not have clinical evidence supporting the opinions and statements of the health care professionals nor accept any responsibility or liability of the healthcare professionals' content. The healthcare professionals have a contractual or other financial relationship with Carl Zeiss Meditec AG and its affiliates and have received financial support. Contact for investorsSebastian FrericksDirector Investor RelationsCarl Zeiss Meditec AGPhone: +49 3641 220 116Mail: Contact for the pressFrank SmithHead of Global Communications OphthalmologyCarl Zeiss Meditec +49 3641 220 331Mail: Brief Profile Carl Zeiss Meditec AG (ISIN: DE0005313704), which is listed on the MDAX and TecDAX of the German stock exchange, is one of the world's leading medical technology companies. The Company supplies innovative technologies and application-oriented solutions designed to help doctors improve the quality of life of their patients. The Company offers complete solutions, including implants and consumables, to diagnose and treat eye diseases. The Company creates innovative visualization solutions in the field of microsurgery. With 5,730 employees worldwide, the Group generated revenue of €2,066.1m in fiscal year 2023/24 (to 30 September). The Group's head office is located in Jena, Germany, and it has subsidiaries in Germany and abroad; more than 50 percent of its employees are based in the USA, Japan, Spain and France. The Center for Application and Research (CARIn) in Bangalore, India and the Carl Zeiss Innovations Center for Research and Development in Shanghai, China, strengthen the Company's presence in these rapidly developing economies. Around 39 percent of Carl Zeiss Meditec AG's shares are in free float. Approx. 59 percent are held by Carl Zeiss AG, one of the world's leading groups in the optical and optoelectronic industries. For further information visit: View original content to download multimedia: SOURCE Carl Zeiss Meditec AG View original content to download multimedia: Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store